Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice

Study Overview
=================
Brief Summary
-----------------
Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. There is evidence that ambulatory blood pressure monitoring (ABPM) results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. New international guidelines recognize the importance of ABPM which has an important and growing role in the diagnosis and in guiding antihypertensive therapy. In 2011 in the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommended that ABPM be performed on all patients with suspected hypertension to confirm the diagnosis and reduce unnecessary treatment in people who do not have true hypertension. The aim of this observational study is to describe the utility of ABPM generally and specifically in the management of hypertension by Cardiologists in the Algerian context.

Detailed Description
-----------------
The primary Objective of this study is to assess the benefit of the ABPM in the diagnosis and management of arterial hypertension in by Cardiologists. The Secondary Objectives are: To identify the conditions of usage of ABPM for the diagnosis of arterial hypertension, To evaluate the blood pressure during the ABPM assessment and at 6 weeks of follow up To describe the study population (socio-demography), To describe the therapeutic stratégies and the compliance to treatment.

Official Title
-----------------
ABPM (Automatic Measurement of Blood Pressure) Evaluation in the Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice

Conditions
-----------------
Arterial Hypertension

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who are either hypertensive (defined as those with a clinic SBP ≥ 140 mmHg or DBP ≥ 90 mmHg [7]) or referred for the assessment of hypertension Informed consent obtained before any study-related activity Exclusion Criteria: ABPM contraindication Patient with psychiatric disorder Patient not able to comply with study-related procedures based on clinical judgement of the investigator

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Diagnosis of hypertension | Valid 24h-ABPM: blood pressure ≥ 140/90 mmHg | At 24 hours after the inclusion in the study (Visit 2) | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient Demography | Age, Sexe | At the Inclusion in the study | 
| Therapeutic Decison | Initiation of antihypertensive therapy in naive patients if the dianosis of hypertension is confirmed. Maintain, switch or adaptation of treatment in treated patients. | At 24 hours after the inclusion in the study (Visit 2) | 
| Self-measurement of Arterial blood Pressure | Measurement of arterial pressure performed by the patient and reported on a follow up diary. Both systolic and diastolic pressures will be collected. | At 6 weeks after the inclusion in the study (Visit 3) | 
| Evaluation of Compliance to treatment | Evaluation test based on the method developed by Xavier Girerd, consisting in 6 questions on the compliance. The rating is divised in three categories: Good compliant, moderate compliant or non compliant. according to Girerd et al. Evaluation de l'observance par l'interrogatoire au cours du suivi des hypertendus dans des consultations spécialisées - Arch Mal Cœur Vaiss. 2001 Aug. 94-(8):839-42. | At 6 weeks after the inclusion in the study (Visit 3) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Hypertension, ABPM